Flow cytometry is a powerful technique for analyzing the physical and chemical characteristics of cells in breast cancer samples. Alfa Cytology offers a comprehensive suite of breast cancer flow cytometry analysis services.
Breast cancer (BC), the most common malignancy in women worldwide, is a very heterogeneous disease characterized by a diverse molecular profile. Flow cytometry is a technology that can quickly, accurately, and objectively analyze multiple characteristics of each cell or subcellular structure that passes through the detector. While analyzing these detection substances, it can also sort specific groups. The technology is widely used in the detection and analysis of a variety of diseases, including malignancies, where it can provide diagnostic recommendations, guide treatment, and be used to track disease progression. Especially in the early stages of anti-tumor drug development, complex cell analysis through flow cytometry technology can provide scientific researchers with maximum effective data.
Fig.1 A general outline of a flow cytometer showing a sorting instrument capable of isolating individual cells. On the right side of the figure are examples of possible analyses. (Robinson JP, et al., 2023)
Alfa Cytology flow cytometry technology platform is dedicated to exploring and gaining insights into the progress of breast tumor immune-targeted therapy drugs and providing accurate and reliable trial prediction data for the early development stage. Our team has extensive experience in experimental operations, flow method development, and data analysis.
Alfa Cytology boasts extensive expertise in BC research garnered over many years. We are committed to continuous innovation, perpetually exploring improved solutions for our clientele, and ensuring the delivery of top-notch products and services. If you are interested in learning more about our BC flow cytometry analysis services, please don't hesitate to contact us. Our dedicated and knowledgeable staff will promptly get in touch with you.
Reference